Over 11,000 Comments Submitted on DEA’s Marijuana Rescheduling Plan, Vast Majority Oppose Schedule I Status

In the two weeks since the Drug Enforcement Administration (DEA) filed its plan in the Federal Register to reschedule marijuana, public engagement has surged, resulting in over 11,000 comments submitted.

Upon the DEA’s submission of its proposal on May 21, a 60-day public comment period was officially initiated, set to conclude on July 22. In the following 15 days, 11,100 comments have been submitted, averaging nearly 800 each day.

Approximately 60% of these comments support further action to completely deschedule marijuana. Less than 5% of the total comments are urging the DEA to keep marijuana as a Schedule I drug, meaning it would remain illegal for all purposes under all circumstances.

If implemented, the DEA’s proposal would shift marijuana from a Schedule I to a Schedule III substance. This reclassification would allow for the legal prescription of medications containing marijuana and its compounds across the country, once they receive FDA approval. It would also provide state-legal medical marijuana patients and businesses with federal protections that are currently not available to them.

Recently a DEA official told us that a finalized ruling is on track to be issued “by the end of September, but as soon as the end of August.”

All comments to the DEA are publicly accessible and can be viewed by clicking here. You can submit your own comments to the DEA by clicking here.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here.

More articles from The Marijuana Herald:

Rhode Island Lawmakers File Bill to Create “RICare” Universal Healthcare System, Ban Premiums and Copays

Rhode Island Lawmakers File Bill to Create “RICare” Universal Healthcare System, Ban Premiums and Copays

CBD May Help Limit the “Second Wave” of Brain Damage After Traumatic Brain Injury, Study Finds

CBD May Help Limit the “Second Wave” of Brain Damage After Traumatic Brain Injury, Study Finds

CB1 Activation Helps Speed Wound Healing, Reports Study

CB1 Activation Helps Speed Wound Healing, Reports Study

Florida Senate Committee to Vote Feb. 18 on Bill Tightening Low-THC Marijuana Rules and Expanding Buffer Zones for Dispensaries

Florida Senate Committee to Vote Feb. 18 on Bill Tightening Low-THC Marijuana Rules and Expanding Buffer Zones for Dispensaries

Study: CBD Kills Rare Ovarian Tumor Cells by Targeting TRPV2 Channel and Mitochondrial Pathway

Study: CBD Kills Rare Ovarian Tumor Cells by Targeting TRPV2 Channel and Mitochondrial Pathway

Edible Hemp Film Helped Keep Freeze-Dried Berries Fresher in Storage, Study Finds

Edible Hemp Film Helped Keep Freeze-Dried Berries Fresher in Storage, Study Finds

Maryland Cannabis Industry Generates $98.9 Million in Sales in January, Prices down 12% from January 2025

Maryland Cannabis Industry Generates $98.9 Million in Sales in January, Prices down 12% from January 2025

Utah Committee Advances Bill to Allow Medical Marijuana Telehealth Recommendations, Expand Low-THC Products in Pharmacies

Utah Committee Advances Bill to Allow Medical Marijuana Telehealth Recommendations, Expand Low-THC Products in Pharmacies

New York Bill Would Let Liquor Stores Sell Low-THC Cannabis Beverages, Taxed at 9% Wholesale and 13% Retail

New York Bill Would Let Liquor Stores Sell Low-THC Cannabis Beverages, Taxed at 9% Wholesale and 13% Retail

U.S. Congress: Legislation to End Cannabis Prohibition Nationwide and Allow Expungements Gains Sponsors from Nearly 30 States and D.C.

U.S. Congress: Legislation to End Cannabis Prohibition Nationwide and Allow Expungements Gains Sponsors from Nearly 30 States and D.C.

Bipartisan Oregon Bill Would Allow Physician-Supervised Ibogaine Treatment

Bipartisan Oregon Bill Would Allow Physician-Supervised Ibogaine Treatment

Virginia Bill to Require Hospitals to Allow Medical Marijuana for Terminally Ill Patients Approved by Committee

Virginia Bill to Require Hospitals to Allow Medical Marijuana for Terminally Ill Patients Approved by Committee

Tilray Expands UK Medical Supply Network Through New Distribution Deal With Smartway Pharmaceuticals

Tilray Expands UK Medical Supply Network Through New Distribution Deal With Smartway Pharmaceuticals

Virginia House Appropriations Committee Advances Bill to Legalize Recreational Cannabis Sales 16 to 6

Virginia House Appropriations Committee Advances Bill to Legalize Recreational Cannabis Sales 16 to 6

New York Legislature Passes Bill Allowing Marijuana Dispensaries Near Houses of Worship, Sends Measure to Governor

New York Legislature Passes Bill Allowing Marijuana Dispensaries Near Houses of Worship, Sends Measure to Governor

Florida Appeals Court Upholds State’s THC Limits on Hemp Products

Florida Appeals Court Upholds State’s THC Limits on Hemp Products

U.S. Congress: Legislation to Prevent Cannabis Businesses From Taking Tax Deductions Following Rescheduling Gains 15th Sponsor

U.S. Congress: Legislation to Prevent Cannabis Businesses From Taking Tax Deductions Following Rescheduling Gains 15th Sponsor

New York Senate Committee Advances Bill Allowing Parolees and Probationers to Work in Legal Marijuana Industry

New York Senate Committee Advances Bill Allowing Parolees and Probationers to Work in Legal Marijuana Industry